EA201890889A1 - Композиция, содержащая ниацинамид и пиколинамид - Google Patents

Композиция, содержащая ниацинамид и пиколинамид

Info

Publication number
EA201890889A1
EA201890889A1 EA201890889A EA201890889A EA201890889A1 EA 201890889 A1 EA201890889 A1 EA 201890889A1 EA 201890889 A EA201890889 A EA 201890889A EA 201890889 A EA201890889 A EA 201890889A EA 201890889 A1 EA201890889 A1 EA 201890889A1
Authority
EA
Eurasian Patent Office
Prior art keywords
picolinamide
composition containing
niacinamide
composition
containing niacinamide
Prior art date
Application number
EA201890889A
Other languages
English (en)
Other versions
EA035789B1 (ru
Inventor
Амитабха Маджумдар
Мрутхиунджая Свами Матхапатхи
Original Assignee
Юнилевер Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнилевер Н.В. filed Critical Юнилевер Н.В.
Publication of EA201890889A1 publication Critical patent/EA201890889A1/ru
Publication of EA035789B1 publication Critical patent/EA035789B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к композиции для местного применения и, в частности, к композиции для местного применения для антимикробного эффекта. В соответствии с настоящим изобретением предлагается композиция для местного применения, содержащая ниацинамид и пиколинамид, при этом молярное соотношение ниацинамида к пиколинамиду составляет от 1:20 до 20:1.
EA201890889A 2015-10-05 2016-10-04 Композиция, содержащая ниацинамид и пиколинамид EA035789B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15188360 2015-10-05
PCT/EP2016/073626 WO2017060213A1 (en) 2015-10-05 2016-10-04 Composition comprising niacinamide and picolinamide

Publications (2)

Publication Number Publication Date
EA201890889A1 true EA201890889A1 (ru) 2018-09-28
EA035789B1 EA035789B1 (ru) 2020-08-11

Family

ID=54256684

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201890886A EA035440B1 (ru) 2015-10-05 2016-10-04 Композиция для осветления кожи
EA201890889A EA035789B1 (ru) 2015-10-05 2016-10-04 Композиция, содержащая ниацинамид и пиколинамид

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201890886A EA035440B1 (ru) 2015-10-05 2016-10-04 Композиция для осветления кожи

Country Status (13)

Country Link
US (3) US10952952B2 (ru)
EP (2) EP3359261B1 (ru)
JP (2) JP6907196B2 (ru)
KR (1) KR102643373B1 (ru)
CN (2) CN108136232B (ru)
AR (1) AR106261A1 (ru)
BR (1) BR112018005742B1 (ru)
CA (2) CA3000296A1 (ru)
EA (2) EA035440B1 (ru)
MX (2) MX2018004143A (ru)
PH (1) PH12018500619B1 (ru)
WO (2) WO2017060211A1 (ru)
ZA (2) ZA201802005B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018004143A (es) * 2015-10-05 2018-06-13 Unilever Nv Composicion que comprende niacinamida y picolinamida.
CN111491612B (zh) 2017-12-18 2023-10-20 联合利华知识产权控股有限公司 局部组合物
CN114096233A (zh) * 2019-07-12 2022-02-25 联合利华知识产权控股有限公司 生物能量的组合和使用其的方法
WO2021249760A1 (en) * 2020-06-10 2021-12-16 Unilever Ip Holdings B.V. A cosmetic composition comprising 6-methyl-picolinamide
US11696889B2 (en) 2020-08-07 2023-07-11 David Levy Botanical antimicrobial composition
WO2023175061A1 (en) * 2022-03-18 2023-09-21 Unilever Ip Holdings B.V. A skin brightening composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
GB8910366D0 (en) * 1989-05-05 1989-06-21 Unilever Plc Skin composition
TW233264B (ru) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
AU3082699A (en) 1998-03-16 1999-10-11 Procter & Gamble Company, The Method of treating skin irritation
JP2003529590A (ja) 2000-03-21 2003-10-07 アスション デヴェロップメント エーピーエス ピリジンカルボキシ誘導体およびｈ２ヒスタミン受容体アンタゴニストからなる化学的複合体
US20030105034A1 (en) 2001-07-05 2003-06-05 Astion Deveopment A/S Pyridine carboxy derivatives and an aminosugar
FR2827763B1 (fr) 2001-07-24 2005-09-23 Cs Substance alkyloside inhibant la fixation de microorganismes, utilisation topique et composition contenant au moins une telle substance
JP3908969B2 (ja) 2002-03-18 2007-04-25 ピアス株式会社 化粧料
DE60308891T2 (de) 2002-06-20 2007-05-24 Astion Dermatology A/S Neue komplexe von polyhydroxyalkanfettsäureestern und niacinamid
JP2004123554A (ja) 2002-09-30 2004-04-22 Pias Arise Kk 皮膚バリア機能改善物質、皮膚のしわ改善物質、および該物質を含む皮膚外用剤、化粧料および医薬部外品
US20090105188A1 (en) 2007-10-17 2009-04-23 Nationwide Children's Hospital, Inc. Compositions and Methods for Treating Necrotizing Enterocolitis
US20090317341A1 (en) 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
WO2010002586A2 (en) 2008-06-30 2010-01-07 Elc Management Llc Topical compositions comprising isonicotinamide
AU2009314165B2 (en) * 2008-11-11 2014-05-15 Signum Biosciences, Inc. Isoprenyl compounds and methods thereof
WO2011133692A1 (en) 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds
US20140161750A1 (en) * 2012-12-12 2014-06-12 Thomas Christopher Balshi Sunscreen composition with pigment correcting properties
EP3120850B1 (en) * 2012-12-14 2018-11-07 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides
US9597271B2 (en) 2013-10-24 2017-03-21 The Procter & Gamble Company Cosmetic compositions and methods
CN106413680A (zh) 2014-05-12 2017-02-15 荷兰联合利华有限公司 用于诱导抗微生物肽生成的烟酰胺
MX2018004143A (es) * 2015-10-05 2018-06-13 Unilever Nv Composicion que comprende niacinamida y picolinamida.

Also Published As

Publication number Publication date
EP3359261B1 (en) 2019-05-15
CN108135824A (zh) 2018-06-08
WO2017060213A1 (en) 2017-04-13
US20200230045A1 (en) 2020-07-23
MX2018004143A (es) 2018-06-13
US20180280278A1 (en) 2018-10-04
JP6880011B2 (ja) 2021-06-02
EA035440B1 (ru) 2020-06-15
ZA201802005B (en) 2019-07-31
CA3000880A1 (en) 2017-04-13
KR20180054647A (ko) 2018-05-24
EP3359124A1 (en) 2018-08-15
CN108135824B (zh) 2021-09-17
US10660840B2 (en) 2020-05-26
PH12018500619A1 (en) 2018-10-01
BR112018005742A2 (pt) 2018-10-09
ZA201802233B (en) 2019-07-31
EA201890886A1 (ru) 2018-09-28
PH12018500619B1 (en) 2018-10-01
CN108136232B (zh) 2021-08-13
US20180296457A1 (en) 2018-10-18
MX365369B (es) 2019-05-31
KR102643373B1 (ko) 2024-03-07
US11298312B2 (en) 2022-04-12
CA3000296A1 (en) 2017-04-13
JP2018529735A (ja) 2018-10-11
EP3359261A1 (en) 2018-08-15
EP3359124B1 (en) 2020-06-03
US10952952B2 (en) 2021-03-23
JP2018529741A (ja) 2018-10-11
CN108136232A (zh) 2018-06-08
JP6907196B2 (ja) 2021-07-21
MX2018004144A (es) 2018-06-13
AR106261A1 (es) 2017-12-27
BR112018005742B1 (pt) 2021-11-16
EA035789B1 (ru) 2020-08-11
WO2017060211A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
EA201890889A1 (ru) Композиция, содержащая ниацинамид и пиколинамид
EA201790722A1 (ru) КОМПОЗИЦИЯ С НИЗКИМ pH, СОДЕРЖАЩАЯ КОНКРЕТНЫЕ КОНСЕРВАЦИОННЫЕ СИСТЕМЫ
EA201891171A1 (ru) Стабильные композиции с инокулянтом и способы их получения
EA201890269A1 (ru) Гербицидная композиция, содержащая цинметилин и напропамид
EA201591137A1 (ru) Ингибиторы mk2 и их применения
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
EA201691534A1 (ru) Лечение устойчивых угрей
EA201891409A1 (ru) Бензамидные соединения и их применение в качестве гербицидов
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201992177A1 (ru) Композиции на основе нирапариба
EA201690314A1 (ru) Анти-garp-белок и его применения
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
BR112015029686A2 (pt) composições para o tratamento de superfícies compreendendo corantes fotocrômicos
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
MX2017006149A (es) Composiciones para el cuidado personal con dos fases beneficas.
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
CY1123194T1 (el) Νεες αντιβακτηριακες ενωσεις
MX2016011897A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
EA201691982A1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
EA201690036A1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
EA201591399A1 (ru) РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM